bioAffinity Technologies, Inc. (BIAF)
1.71
+0.05
(+3.01%)
USD |
NASDAQ |
Dec 10, 16:00
1.67
-0.04
(-2.34%)
After-Hours: 20:00
bioAffinity Technologies EPS Diluted (Quarterly): -4.737 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -0.1646 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.051M |
| Revenue (Quarterly) | 1.446M |
| Total Expenses (Quarterly) | 6.497M |
| Enterprise Value | 0.4795M |
| Gross Profit Margin (Quarterly) | 27.00% |
| Profit Margin (Quarterly) | -349.3% |
| Earnings Yield | -943.0% |
| Normalized Earnings Yield | -783.21 |